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Abstract: Background: Astrocytes (AC) are essential for brain homeostasis. Much data suggests that
AC support and protect the vascular endothelium, but increasing evidence indicates that during injury
conditions they may lose their supportive role resulting in endothelial cell activation and BBB distur-
bance. Understanding the triggers that flip this switch would provide invaluable information for designing
new targets to modulate the brain vascular compartment. Hypoxia-inducible factor-1 (HIF-1) has long
been assumed to be a culprit for barrier dysfunction as a number of its target genes are potent angio-
genic factors. Indeed AC themselves, reservoirs of an array of different growth factors and molecules,
are frequently assumed to be the source of such molecules although direct supporting evidence is yet
to be published. Being well known reservoirs of HIF-1 dependent angiogenic molecules, we asked if AC
HIF-1 dependent paracrine signaling drives brain EC disturbance during hypoxia. Methods: First we
collected conditioned media from control and siRNA-mediated HIF-1 knockdown primary rat AC that
had been exposed to normoxic or hypoxic conditions. The conditioned media was then used to culture
normoxic and hypoxic (1% O2) rat brain microvascular EC (RBE4) for 6 and 24 h. Various activation
parameters including migration, proliferation and cell cycling were assessed and compared to untreated
controls. In addition, tight junction localization and barrier stability per se (via permeability assay) was
evaluated. Results: AC conditioned media maintained both normoxic and hypoxic EC in a quiescent
state by suppressing EC metabolic activity and proliferation. By FACs we observed reduced cell cycling
with an increased number of cells in G0 phase and reduced cell numbers in M phase compared to con-
trols. EC migration was also blocked by AC conditioned media and in correlation hypoxic tight junction
organization and barrier functionality was improved. Surprisingly however, AC HIF-1 deletion did not
impact EC responses or barrier stability during hypoxia. Conclusions: This study demonstrates that AC
HIF-1 dependent paracrine signaling does not contribute to AC modulation of EC barrier function under
normoxic or hypoxic conditions. Thus other cell types likely mediate EC permeability in stress scenar-
ios. Our data does however highlight the continuous protective effect of AC on the barrier endothelium.
Exploring these protective mechanisms in more detail will provide essential insight into ways to prevent
barrier disturbance during injury and disease.
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Astrocyte-specific hypoxia-inducible factor 1 
(HIF-1) does not disrupt the endothelial barrier 
during hypoxia in vitro
Julia Baumann1,2, Chih‑Chieh Tsao1, Sheng‑Fu Huang1, Max Gassmann1 and Omolara O. Ogunshola1*  
Abstract 
Background: Astrocytes (AC) are essential for brain homeostasis. Much data suggests that AC support and pro‑
tect the vascular endothelium, but increasing evidence indicates that during injury conditions they may lose their 
supportive role resulting in endothelial cell activation and BBB disturbance. Understanding the triggers that flip this 
switch would provide invaluable information for designing new targets to modulate the brain vascular compartment. 
Hypoxia‑inducible factor‑1 (HIF‑1) has long been assumed to be a culprit for barrier dysfunction as a number of its tar‑
get genes are potent angiogenic factors. Indeed AC themselves, reservoirs of an array of different growth factors and 
molecules, are frequently assumed to be the source of such molecules although direct supporting evidence is yet to 
be published. Being well known reservoirs of HIF‑1 dependent angiogenic molecules, we asked if AC HIF‑1 depend‑
ent paracrine signaling drives brain EC disturbance during hypoxia.
Methods: First we collected conditioned media from control and siRNA‑mediated HIF‑1 knockdown primary rat AC 
that had been exposed to normoxic or hypoxic conditions. The conditioned media was then used to culture nor‑
moxic and hypoxic (1%  O2) rat brain microvascular EC (RBE4) for 6 and 24 h. Various activation parameters including 
migration, proliferation and cell cycling were assessed and compared to untreated controls. In addition, tight junction 
localization and barrier stability per se (via permeability assay) was evaluated.
Results: AC conditioned media maintained both normoxic and hypoxic EC in a quiescent state by suppressing EC 
metabolic activity and proliferation. By FACs we observed reduced cell cycling with an increased number of cells in G0 
phase and reduced cell numbers in M phase compared to controls. EC migration was also blocked by AC conditioned 
media and in correlation hypoxic tight junction organization and barrier functionality was improved. Surprisingly 
however, AC HIF‑1 deletion did not impact EC responses or barrier stability during hypoxia.
Conclusions: This study demonstrates that AC HIF‑1 dependent paracrine signaling does not contribute to AC 
modulation of EC barrier function under normoxic or hypoxic conditions. Thus other cell types likely mediate EC per‑
meability in stress scenarios. Our data does however highlight the continuous protective effect of AC on the barrier 
endothelium. Exploring these protective mechanisms in more detail will provide essential insight into ways to prevent 
barrier disturbance during injury and disease.
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Background
Astrocytes (AC) are key regulators of CNS homeosta-
sis. Being one of the most abundant cell types in the 
brain they play crucial roles in both brain health and 
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disease [1]. They are essential in regulating cerebral ion 
homeostasis [2] and give structural and metabolic sup-
port to neurons [3, 4]. AC also play a key role in effective 
functioning of the blood–brain barrier (BBB), and neu-
rovascular unit (NVU) as a whole. The BBB is a critical 
interface between the circulatory system and the CNS 
that has a unique vascular architecture. The vessels are 
composed of specialized brain endothelial cells (EC) 
that form a restrictive barrier due to high expression of 
tight junction (TJ) proteins [5] and various transporters 
and enzymes that selectively facilitate nutrient trans-
port while preventing toxin and pathogen entry [6]. The 
EC are surrounded by AC end-feet and pericytes, which 
cover the majority of the abluminal vascular surface and 
induce and strengthen barrier functionality [7, 8]. As 
the cellular link between the vascular compartment and 
brain parenchyma, AC are thought to be a major integra-
tion site of brain metabolism and function [9].
Astrocytes are known to secrete a large number of 
substances including peptides, growth factors and 
chemokines several of which sustain and/or modulate 
barrier function [4, 10–13]. They are also highly stress 
resistant, a feature that facilitates their neuro- and cyto-
protective roles. During injury for instance they retain 
the ability to take up and/or recycle potassium and glu-
tamate as well as release mitogenic and metabolic factors 
such as ATP that can aid surrounding cells including EC 
[3, 4]. However injury conditions can cause AC prolifera-
tion and retraction of their end-feet from vessel walls, 
resulting in increased BBB permeability [1, 14]. Addition-
ally, altered molecular and metabolic signaling can also 
activate barrier EC leading to BBB disturbance [7]. Since 
an uncompromised and stable BBB is highly dependent 
on maintenance of a non-activated quiescent EC state, 
understanding how AC respond to different insults is 
important to prevent vascular leakage and limit subse-
quent brain damage.
A key regulator of stress-induced cellular responses, 
and angiogenesis in general, is hypoxia-inducible fac-
tor 1 (HIF-1). HIF-1 is a heterodimer consisting of an 
unstable oxygen dependent α-subunit and a β-subunit 
that is permanently expressed in the nucleus [15]. Under 
normal physiological conditions the α-subunit is con-
stantly degraded but during injury it is stabilized, trans-
locates to the nucleus and dimerizes with the β-subunit. 
Subsequent co-factor recruitment leads to the forma-
tion of the functional protein complex and induction of 
downstream target genes such as glucose transporter-1 
(Glut1), matrix metalloproteinase-9 (MMP9) and vas-
cular endothelial growth factor (VEGF). HIF-1 target 
genes promote mechanisms that facilitate cellular and 
organ adaptation to stress conditions [15]. Although 
HIF-1 mediated vascular remodeling benefits hypoxic or 
ischemic tissue recovery in non-cerebral vascular beds 
[16] an increasing number of in  vitro and in  vivo stud-
ies provide convincing evidence that HIF-1 stabilization 
in the brain induces BBB dysfunction. For example in 
various rat models of cerebral focal ischemia, pharma-
cological HIF-1 inhibition reduced infarct volume, BBB 
permeability and edema formation post stroke [17–20]. 
Although the HIF-1 target gene VEGF frequently plays a 
role in such studies, the cellular origin(s) of the negative 
signals remain largely unidentified. In this regard in vitro 
studies have provided important insight. Activation of 
the HIF-1 pathway in iPSC-derived brain EC impaired 
BBB stability in correlation with a loss of the TJ claudin-5 
expression [21]. Similarly, HIF-1 inhibition in rat brain 
EC prevented hypoxic TJ delocalization and permeabil-
ity increase [18, 22]. Thus one of the major sources seems 
to be the endothelium itself. Nevertheless perivascu-
lar cells are also likely to play an instrumental role dur-
ing stress in  vivo. As well-known reservoirs of HIF-1 
dependent angiogenic molecules, AC in particular could 
be perpetuators of injury-induced BBB disruption [23, 
24]. Indeed, increased AC VEGF levels and secretion has 
been shown to compromise or correlate with barrier sta-
bility in inflammatory models in vivo [25, 26] and in vitro 
[27]. However, despite being widely assumed the culprit 
during all scenarios, it is still unclear whether induction 
of the AC HIF-1 signaling pathway mediates vascular 
remodeling and BBB disruption.
We therefore asked if hypoxia-induced AC HIF-1-de-
pendent paracrine signaling activates brain EC and 
drives barrier disturbance. We exposed hypoxic brain 
EC to conditioned media obtained from control and 
HIF-1 knockdown (KD) primary rat astrocytes exposed 
to normoxia or oxygen deprivation. A number of activa-
tion parameters, survival as well as barrier stability were 
measured. Our data convincingly shows that AC condi-
tioned media protects the endothelial barrier in all con-
ditions but surprisingly HIF1 signaling per se had no 
impact.
Materials and methods
Primary astrocyte isolation and cell culture
Primary rat astrocytes were isolated from neonatal 
pups according to an established protocol [22, 28]. In 
short, pups were anesthetized by hypothermia, decapi-
tated and the brains removed. The cortical tissue was 
excised, meninges removed and mechanically dissoci-
ated, digested for 12  min at 37  °C. The digestion was 
stopped with DNase1 (Roche, Switzerland) and trypsin 
inhibitor (Gibco®, Life Technologies, Switzerland) then 
triturated. After centrifugation the cell pellet was resus-
pended in astrocyte media and plated on gelatin-coated 
petri dishes. AC were cultured in DMEM supplemented 
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with 10 % FBS (Gibco®), 1 % Penicillin/Streptomycin 
(Gibco®), 2mM l-glutamine (Gibco®) and 50  µg/mL 
gentamycin sulphate (AppliChem, Germany). Cells were 
used after first passage. The rat brain endothelial cell line 
RBE4 [22, 28] was used between passage 36 and 49. Cells 
were maintained on 250  µg/mL rat-tail collagen coated 
petri dishes in a 1:1 αMEM/Ham’s F-10 medium mixture 
(Gibco®) supplemented with 10 % FBS, 300 µg/mL Gene-
ticin (Gibco®) and 1ng/mL basic fibroblast growth fac-
tor (Pepro Tech, USA). Rat-tail collagen was isolated as 
previously described [22, 28]. All cells were cultured in a 
humidified incubator at 37 °C, 5%  CO2 and 21%  O2.
siRNA transfection
Transfection of 90% confluent primary AC was per-
formed with Oligofectamine™ transfection reagent (Inv-
itrogen, Thermo Fischer Scientific, USA) with HIF-1α 
targeting siRNA or a non-targeting scrambled siRNA 
control (100nM, On-TARGETplus, Dharmacon Horizon 
Discovery, UK). Oligofectamine™ was premixed in Opti-
MEM® (Gibco®) and incubated for 10 min before being 
added to siRNA diluted in Opti-MEM®. After further 
20 min incubation at room temperature, the transfection 
mix was added dropwise to AC in serum free media and 
incubated for 6 h before replacement with normal culture 
media. Experiments were subsequently performed after 
48 h.
Hypoxic and conditioned media exposures
O2 deprivation was performed in a hypoxic glove box 
chamber at 37  °C, 5%  CO2 and 1%  O2  (InVivO2 400, 
Ruskinn Technologies, UK) for 6 h and 24 h. Normoxic 
controls were maintained at 37 °C, 5%  CO2 and 21%  O2. 
AC-conditioned media (AC-CM) was collected post 
exposure, immediately snap frozen then stored at − 80 °C 
until use. On thawing AC-CM was quickly added to cul-
tured RBE4 immediately prior to exposure. A schematic 
overview of the experimental setup showing conditioned 
media exchange between primary AC and EC, work flow 
of media transfer and performed analysis is presented in 
Fig. 1.
Cell migration
Migration experiments were performed in duplicate on 
confluent RBE4 cells grown in 6-well plates. Cells were 
scratched vertically with a 200  µL pipette tip and three 
pictures taken per scratch before and after the exposures 
at marked intervals with an inverted microscope coupled 
to an 8-bit CCD camera (Axiocam HR, Carl Zeiss, Swit-
zerland). Image analysis to determine scratch width was 
done using ImageJ software (NIH, USA). Mean migra-
tion (µm/h) of the cells was determined by dividing the 
amount of scratch width closure (µm) by the exposure 
time (h).
Cell viability
MTT assay was used to assess viability of confluent cells 
grown on 96 well plates. After exposures, MTT solu-
tion (Sigma-Aldrich, USA) was added to the media (final 
concentration 0.5  mg/mL) and plates incubated for 1  h 
at 37  °C. The solution was then removed and formazan 
crystals dissolved in DMSO (Sigma-Aldrich). All condi-
tions were run in triplicate. Optical density was measured 
at 570 nm on a spectrophotometer (Thermo Labsystems, 
Multiskan RC Model 351) with reference filter at 670 nm.
Western blotting
Cells were washed with ice cold PBS and lysed in whole 
cell lysis buffer (50  mM Tris, 150  mM NaCl, 1% Triton 
X-100, 1% NP-40) supplemented with protease inhibitor 
cocktail (Calbiochem, Germany), 1  mM sodium ortho-
vanadate and 0.5  mM phenylmethansulfonyl fluoride. 
Protein concentrations were determined with a Pierce 
BCA protein assay (Thermo Fischer Scientific, USA). 
Total proteins (30  µg) were separated by SDS-PAGE on 
10% gels and transferred onto nitrocellulose membranes 
(Amersham™ 0.45  μm, Germany). Membranes were 
blocked with 5% non-fat dried milk dissolved in TBS 
and incubated at + 4  °C overnight in primary antibod-
ies against HIF-1α (NB100-479  W-1, 1:1000, Novusbio) 
and β-actin (A5441, 1:5000, Sigma-Aldrich). Membranes 
were washed with 0.1% Tween-20 TBS then incubated 
HRP-conjugated secondary antibody in TBS (Jackson 
ImmunoResearch, UK). Bands were detected with a 
luminescent image analyzer (Fujifilm, LAS-3000, Swit-
zerland) and a homemade detection solution or the 
sensitive SuperSignal West Femto Substrate (Thermo 
Fischer). Quantification was performed with ImageJ soft-
ware (NIH, USA) using β-actin as loading control.
Quantitative real‑time PCR
RNA was extracted from cell cultures with TRIzol® 
reagent (Thermo Fisher) according to the manufac-
turers’ instructions. One µg of total RNA was reverse 
transcribed using the ImProm-II ReverseTranscriptase 
kit (Promega, Switzerland) with oligo-dT primers 
according to the kit protocol. Real-time quantitative 
PCR (qPCR) was performed using Power SYBR® Green 
Master Mix (Applied Biosystems, Switzerland) in an 
ABI 7500 Fast Real-Time PCR System (Applied Biosys-
tems). The following primers (Microsynth AG, Switzer-
land) were used at 100 nm final concentration: VEGF-A 
5′-CGC AAG AAA TCC CGG TTT AA-3′ and 5′-CAA 
ATG CTT TCT CCG CTC TGA-3′, Glut1 5′-GGG 
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CAT GAT TGG TTC CTT CTC-3′ and 5′-CAG GTT 
CAT CAT CAG CAT GGA-3′, CA9 5′-CTC TCT CCG 
TTT CCT TGT GG-3′ and 5′-CCA CTT CTG TGC 
CTG TGC T-3′, MMP9 5′-TCT GCC TGC ACC ACT 
AAA GG-3′ and 5′-CAG GCT GTA CCC TTG GTC 
TG-3′ and β-actin 5′-CTG GCT CCT AGC ACC ATG 
AAG-3′ and 5′-GCC ACC GAT CCA CAC AGA GT-3′. 
Ten-fold cDNA dilution series were used to establish 
optimal primer conditions resulting in > 90% efficiency. 
To exclude primer dimer and off-target amplifications 
melting curves were performed and single target ampli-
fication confirmed by gel electrophoresis. Experiments 
were run in duplicate for each condition. All data was 
normalized to β-actin and fold changes calculated with 
the ΔΔCt method [29].
Fluorescence‑activated cell sorting (FACS)
Trypsinized cells were harvested from 6-well culture 
plates, washed in PBS, then fixed in pre-chilled (− 20 °C) 
70 % ethanol overnight. After washing in FACS buffer 
(1mM EDTA, 2% FBS in PBS) the cells were stained with 
2  µg/mL Hoechst 33,342 (Sigma-Aldrich) for 20  min 
at RT before FACS analysis. Sample fluorescence was 
acquired on a flow cytometer (Gallios 10  C 3  L, Beck-
man Coulter, USA) equipped with a UV laser for Hoechst 
excitation. 50,000 cells were measured at medium speed 
and gated to exclude doublets. Selective separation of G1, 
Fig. 1 Schematic of AC‑CM experiments. Graphical overview of experimental setup using primary AC (dark green) and the RBE4 EC cell line 
(red). Media was collected from normoxic (white) or hypoxic untreated (UNT, teal), scrambled transfected (scram, grey) or siHIF‑1α transfected AC 
(si‑HIF1α, teal‑dashed) and snap frozen before use. Thawed AC‑CM was transferred to confluent RBE4 immediately before exposure. All experiments 
were compared to RBE4 grown in their own culture media (RBE4 media, red)
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S and G2/M cell cycle phases was performed [30] and 
analysis performed with the Kaluza Analysis program 
(Beckman Coulter).
Immunofluorescence
RBE4 cells were seeded on poly-l-lysine (Sigma-Aldrich) 
and rat-tail collagen coated glass coverslips one day 
prior to experiments. Post exposure cells were fixed in 
4% PFA, permeabilized with 0.1% Triton X-100 in PBS, 
then blocked with 10% normal goat serum before incu-
bation in ZO-1 primary antibody overnight at 4 °C. Cells 
were then incubated with Alexa488-conjugated second-
ary antibody (Thermo Fisher, 1:500), then counterstained 
with DAPI (Sigma-Aldrich, 100  nM) and coverslips 
mounted with fluorescent mounting media (Dako, USA). 
To stain the actin cytoskeleton, fixed and blocked cells 
were incubated with rhodamine-conjugated phalloidin 
(Thermo Fisher, 1:10,000) and counterstained with DAPI 
before being mounted. Images were acquired using a flu-
orescence microscope coupled to an 8-bit CCD camera 
(Axiocam HR, Carl Zeiss, Switzerland) and processed 
using ImageJ software (NIH, USA).
Permeability assay
RBE4 were grown to confluency on 0.4 μm polycarbona-
teTranswell inserts (Corning Incorporated, USA), with 
a blank insert used as an empty filter control. AC-CM 
was added to both upper and lower compartments of 
all inserts prior to exposure. After exposure the media 
was replaced with DMEM (Gibco®) with that in the 
upper compartment containing 1  mg/mL Lucifer Yel-
low CH, lithium salt (Invitrogen, Thermo Fischer). Ali-
quots were taken from the bottom compartment at 15, 
30 and 45 min and tracer flux measured with a fluores-
cence plate reader (FLx800, Biotek Instruments, USA). 
After subtracting the baseline permeability of the blank 
insert from the experimental conditions, the permeability 
coefficient (Pe) was calculated from the clearance slope 
obtained from measurements at the different time points 
as previously described [28].
Statistical analysis
Results are expressed as mean values ± standard devia-
tion of at least 3 independent experiments. Statistical 
analysis was performed with GraphPad Prism 6 (Graph-
Pad Software, USA) and significance determined by 
unpaired Student’s t-test with homoscedasticity, or two-
way ANOVA for comparison between different exposure 
groups. Fischer’s LSD post-hoc correction was applied. A 
p value < 0.05 was considered significant.
Results
Confirmation of HIF‑1α deletion in primary astrocytes
To investigate AC HIF-1 dependent paracrine signal-
ling, an in vitro model was established using primary rat 
astrocytes and the rat brain endothelial cell line RBE4. 
Purity of AC cultures was > 98 % as controlled by GFAP 
and GLAST versus Iba1 (microglia), PDGFRß (pericytes) 
and CD31 (endothelial) expression levels (Fig. 2a). HIF-1 
KD astrocytes were generated using siRNA targeting 
the HIF-1α (siHIF1α) subunit and controlled with non-
targeting scrambled (scram) or untreated AC (UNT). 
Viability was not affected by the transfection proce-
dure (Fig.  2b). Western blot (Fig.  2c) and quantification 
(Fig. 2d) confirmed hypoxia-induced HIF-1α stabilisation 
at 6 h was abrogated by up to 95% by siRNA treatment. 
Decreased mRNA levels of HIF-1 target genes Glut1 
(Fig. 2e), CA9 (Fig. 2f ) and VEGF-A (Fig. 2g) after 24 h 
hypoxia confirmed long-term KD efficiency.
Astrocyte HIF‑1 paracrine signalling does not affect 
endothelial cell metabolic activity and proliferation
Hypoxic EC activation and resulting angiogenic pro-
cesses, many of which are mediated by HIF-1, can lead 
to BBB disturbance [7, 31]. Hypoxia-induced BBB dis-
ruption could be mediated by AC-derived molecules as 
the cells have close contact with the barrier endothelium 
and are known reservoirs of HIF-1 dependent angio-
genic factors [23]. We evaluated whether conditioned 
media (AC-CM) of HIF-1 KD AC alters endothelial qui-
escence during normoxia and hypoxia, compared to non-
KD controls. As designated in Fig. 1, cells were exposed 
to control EC media or AC-CM before being incubated 
in normoxia or hypoxia for 6 h or 24 h. AC-CM had no 
effect on EC normoxic or hypoxic metabolic activity as 
measured by MTT conversion during 6  h exposures 
(Additional file 1: Figure S1A). However at 24 h normoxic 
EC cultured in hypoxic AC-CM media had decreased 
metabolic activity compared to cells cultured in nor-
moxic AC-CM or RBE4 culture media (Fig.  3a). Inter-
estingly, KD of AC HIF-1 had no effect. At 24 h, hypoxia 
alone decreased EC metabolic activity but no further 
suppression was observed with AC-CM (Fig.  3a). AC 
HIF-1 KD again had no effect on outcome (Fig. 3a). Simi-
larly EC proliferation, as measured by BrdU incorpora-
tion, remained unchanged at 6 h time points (Additional 
file  1: Figure S1B). During 24  h however AC-CM treat-
ment significantly reduced EC proliferation compared 
to cells held in their own RBE4 media, during normoxia 
and hypoxia (Fig. 3b). Once again however KD of HIF-1 
had no impact EC. Overall these results show that pro-
longed exposure to particularly hypoxic AC-CM pro-
motes EC quiescence by limiting their metabolic activity 
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and proliferation. Notably, AC HIF-1 induction seems to 
not be involved in either process.
AC conditioned media suppresses hypoxia‑induced EC cell 
cycling
EC activation causes the cells to exit the non-dividing 
quiescent G0/G1 phase and start synthesis (S) and active 
mitotic G2/M phases [32]. To further understand how 
AC HIF-1 affects EC activation we evaluated their cell 
cycle phases after exposure to AC KD and control media 
by flow cytometry. EC were simultaneously exposed to 
normoxia and hypoxia for 6 h and 24 h before being har-
vested, fixed and stained with the nuclei dye Hoechst. 




Fig. 2 Confirmation of HIF‑1α deletion in primary astrocytes. a Micrographs showing primary rat astrocytes immunostained for GLAST, GFAP, Iba1, 
CD31, PDGFRβ and NeuN expression, counterstained with DAPI (blue). Scale bar = 200 nm. b MTT conversion of primary AC after 24 h normoxic or 
hypoxic exposure with HIF‑1 KD (siHIF1α) or untreated (UNT) and scrambled controls (scram). c Representative Western blot and d quantification 
of HIF‑1α KD efficiency in primary ACs after 6 h hypoxia. Messenger RNA levels of HIF‑1 target genes Glut1, CA9 and VEGF‑A in primary KD ACs 
compared to normoxic and hypoxic controls after 24 h hypoxia (e–g). Students t‑test and 2way ANOVA, mean ± SD, n = 4–6, *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001 compared to Nx UNT, #p < 0.05, ##p < 0.01 ####p < 0.0001 to Hx UNT, $p < 0.05, $$$p < 0.001 compared to Hx scram
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in Fig.  4a) were gated using width and area parameters 
for G0/G1, synthesis S and interphase/mitosis G2/M 
phases as seen in Fig. 4b. Quantification at 6 h timepoints 
(Additional file 2: Figure S2A–C) showed similar percent-
ages of cells in the different cycle phases during normoxia 
and hypoxia (58.49 ± 7.53% vs. 59.80 ± 5.63% in G0/G1, 
21.81 ± 1.22% vs. 18.76 ± 1.54% in S and 19.04 ± 7.93% vs. 
20.44 ± 4.86% in G2/M respectively) when EC were cul-
tured in their own RBE4 media. Although AC-CM treat-
ment did not alter 6  h normoxic stages during hypoxia 
trends to increased cell percentages in G0/G1 phase 
and decreased numbers in G2/M phase were observed. 
Distinct changes were seen however after prolonged 
exposure as shown in Table  1. After 24  h in their own 
culture media a decreased percentage of cells in G0/G1 
in the hypoxic group (61.06 ± 7.31) compared to the nor-
moxic cells (66.47 ± 5.19) was observed (Table  1). This 
correlated with an increase in the cell percentage in S 
phase (12.47 ± 1.58 vs. 19.01 ± 3.69) indicating hypoxia 
stimulates brain ECs to exit G0/G1 phase (Table  1). 
When treated with AC-CM however the percentage of 
hypoxic cells in G0/G1 was maintained similar to nor-
moxic values (69.22 ± 2.51%) indicating G0/G1 cell cycle 
arrest (Fig.  4d, e). Furthermore decreased percentages 
in the mitotic G2/M phase were noted with AC-CM 
(12.58 ± 1.88%) compared to controls (18.89 ± 3.63%), 
suggesting less proliferation in line with the BrdU assay 
results. Taken together, during prolonged hypoxia 
AC-CM promotes EC G0/G1 cell cycle arrest preventing 
transition to G2/M thereby retaining the EC in a less 
activated state. Notably, AC HIF-1 KD had no additional 
effect suggesting the pathway does not contribute to EC 
cell cycling.
Preventing AC HIF‑1 stabilization does not alter EC 
migration
EC migration is a process that underlies increased BBB 
permeability [7]. We assessed the effect of AC-CM on 
normoxic and hypoxic EC migration and asked whether 
AC HIF-1 signaling plays a role using a classical scratch 
assay. Figure 5a shows representative images of scratched 
EC monolayers before and after 6 h exposure. Quantifica-
tion of mean migration (µm/h) shows that at 6 h AC-CM 
consistently inhibits normoxic and hypoxic EC migra-
tion (Fig. 5b). Although at 24 h a similar effect was seen 
in normoxia, dramatic inhibition of EC migration by 
hypoxia alone (RBE4 media, red bar) was not further sup-
pressed by AC-CM (Fig. 5c). In all conditions, it was clear 
that HIF-1 KD did not impact endothelial migration, 
again agreeing with all other obtained data. Thus AC-
driven inhibition of EC migration is HIF-1-independent.
Protection of barrier functionality by AC‑CM 
is independent of HIF‑1
Cellular migration requires cytoskeletal rearrangement 
resulting in delocalization and/or disruption of EC TJ 
and subsequent BBB impairment [23]. To evaluate bar-
rier functionality we first assessed ZO-1 organization 
a b
Fig. 3 Astrocyte HIF‑1 paracrine signalling does not affect endothelial cell metabolic activity and proliferation. Graphical representation of EC 
a mitochondrial activity and b proliferation as measured by BrdU incorporation after 24 h exposure. EC were exposed to normoxic or hypoxic 
conditions with AC‑CM or their own RBE4 media. Data is presented in comparison to baseline controls (normoxic RBE4 media control; red bar). 
2way ANOVA, mean ± SD, n = 4–6, *p < 0.05, **p < 0.01, ****p < 0.0001 compared to RBE4 media Nx, φp < 0.05 to RBE4 media Hx
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Fig. 4 AC conditioned media suppresses hypoxia‑induced EC cell cycling. a Representative histogram of FACS performed on EC labeled with the 
DNA dye Hoechst. b Example of single cell selective gating during cell cycle phases G0/G1, S and G2/M. Quantification and graphical representation 
of cell percentages in the individual cell cycle phases during 24 h c normoxic and d hypoxic exposures with AC‑CM. Students t‑test, mean ± SD, 
n = 3–5, φp < 0.05 compared to RBE4 media Hx
Table 1 FACS data showing EC numbers (%) in G0/G1, S and G2/M after 24 h exposure to AC conditioned media
Students t-test mean ± SD, n = 3–5, φp < 0.05 compared to RBE4 media Hx
Media G0/G1 (% cells) S (% cells) G2/M (% cells)
Normoxia RBE4 media 66.47 ± 5.19 12.47 ± 1.58 19.96 ± 5.64
AC‑CM Nx24 UNT 67.37 ± 4.98 12.28 ± 2.22 19.60 ± 3.70
AC‑CM Hx24 UNT 71.77 ± 2.83 10.51 ± 0.87 16.97 ± 2.08
AC‑CM Hx24 scram 68.30 ± 4.11 11.44 ± 2.93 19.45 ± 4.05
AC‑CM Hx24 siHIF1α 69.35 ± 2.18 11.30 ± 3.50 18.23 ± 3.11 
Hypoxia RBE4 media 61.06 ± 7.31 19.01 ± 3.69 16.18 ± 3.94
AC‑CM Nx24 UNT 70.31 ± 3.16φ 16.19 ± 4.23φ 11.98 ± 1.21φ
AC‑CM Hx24 UNT 68.37 ± 17.37φ 17.37 ± 4.39φ 12.46 ± 3.14φ
AC‑CM Hx24 scram 69.86 ± 1.42φ 15.90 ± 3.90φ 12.13 ± 2.54φ
AC‑CM Hx24 siHIF1α 69.70 ± 1.76φ 16.20 ± 1.83φ 12.25 ± 3.32φ
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by immunostaining as this key adaptor protein links TJs 
to the cell cytoskeleton and is delocalized in hypoxic 
EC in a HIF-1-dependent manner [22]. Representative 
ZO-1 fluorescent images of EC monolayers after 24  h 
exposure with AC-CM are presented in Fig.  6. Control 
normoxic EC display characteristic cobblestone mor-
phology (Fig.  6a) with ZO-1 continuously expressed at 
cell–cell borders without gap formation, demonstrating 
a
b c
Fig. 5 AC HIF‑1 KD does not alter EC migration. a Representative images of scratched confluent EC monolayers at 0 h and after 6 h exposure. 
Scale bar = 100 μm. EC were scratched and subsequently treated with RBE4 media or normoxic and hypoxic AC‑CM, then exposed to normoxia 
or hypoxia for 6 h or 24 h. After quantification mean migration is graphed as µm/h for b 6 h and c 24 h. 2way ANOVA, mean ± SD, n = 3, *p < 0.05, 
**p < 0.01 ***p < 0.001, ****p < 0.0001 compared to RBE4 media Nx, φp < 0.05, φφp < 0.01, φφφp < 0.001 to RBE4 media Hx
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tight association between neighbouring cells. Exposure 
to AC-CM did not alter normoxic ZO-1 localization and 
the EC monolayer remained intact. As expected hypoxic 
exposure induced characteristic ZO-1 disruption, inter-
endothelial gap formation and cell swelling in monolay-
ers cultured in their own media compared to normoxic 
controls. Notably, these hypoxic effects were abrogated 
when ECs were cultured in normoxic AC-CM (Fig.  6a). 
Furthermore, when cultured in hypoxic AC-CM, despite 
occurrence of hypoxia-induced cell swelling no gap for-
mation at the cell borders was observed. Indeed, the 
monolayer remained largely intact and ZO-1 localization 
was maintained at the cell–cell borders similar to nor-
moxic controls (Fig.  6a). Phalloidin cytoskeleton stain-
ing showed normoxic EC display organised F-actin at cell 
borders and a cortical actin ring demonstrating intact 
cell contacts within the monolayer (Fig. 6b). In contrast, 
hypoxia induced clear disorganisation of actin bundles, 
widespread stress fiber assembly (highlighted by arrows) 
and inter-endothelial gap formation (asterisks). AC-CM 
however improved cell contacts and prevented hypoxic 
gap formation with a more intact cortical actin ring being 
visible. The improvements were most evident in hypoxic 
EC treated with normoxic AC-CM (Fig.  6b). The func-
tional consequence of these observations was revealed by 
in vitro permeability assays. As seen in Fig. 6c, hypoxia-
induced permeability occurred as expected compared to 
the normoxic baseline when EC were cultured in their 
own media. Importantly, injury-induced permeability 
was completely abrogated to levels below the normoxic 
baseline by all AC-CM, with no evident effect of HIF-1 
KD. We conclude that astrocyte conditioned media per 
se suppresses barrier disturbance by maintaining TJ 
localization thereby fostering intact and tight cell–cell 
contacts.
Discussion
It has been long known that AC have growth factor 
reserves that support and protect the vascular endothe-
lium during stress conditions. More recently however 
increasing evidence has shown that perivascular cells 
may lose their supportive roles during injury result-
ing in activation of the microvascular endothelium and 
BBB disturbance. Understanding the triggers that flip 
these switches would provide invaluable information 
for designing new targets to modulate the brain vascu-
lar compartment. As many potent angiogenic factors are 
HIF-1 target genes, we performed conditioned media 
experiments to evaluate whether AC HIF-1-mediated 
paracrine signaling could drive endothelial activation 
and migration. We consistently observed that AC condi-
tioned media prevented hypoxia-induced EC cell cycling 
and migration, improved endothelial barrier integrity and 
prevented hypoxia-induced increases in permeability. 
Surprisingly however, deletion of AC HIF-1 did not alter 
injury-induced EC responses or barrier stability during 
hypoxia suggesting astrocyte-endothelial paracrine sign-
aling is critical for BBB stability but HIF-1 independent.
Vascular homeostasis depends on the balance of pro- 
and anti-angiogenic factors and is tightly regulated by 
inter- and intracellular signaling pathways, as well as 
interactions between cells and the extracellular matrix 
[7, 32]. Under physiological conditions perivascular 
cells, both AC and pericytes, support the BBB. During 
injury conditions however, increased secretion of HIF-1 
dependent angiogenic molecules by AC has been sug-
gested to detrimentally modulate the barrier endothe-
lium [25, 33]. Despite successfully blocking HIF-1α 
stabilization and induction of HIF-1 dependent mol-
ecules in AC, no impact on EC activation was observed 
in this study. Notably, conditioned medium experiments 
such as this may not wholly capture in  vivo paracrine 
signalling as functional crosstalk between AC and ECs 
is excluded. Despite this, recent in  vivo work from our 
group also revealed that AC-specific conditional HIF-1 
knockout (Gfap/GlastCreERT2:Hif1αfl/fl) does not abro-
gate hypoxia-induced BBB disruption (Ogunshola et  al. 
in preparation). A similar observation was seen in a 
mouse experimental MS model [25]. Interestingly, dele-
tion of the notorious HIF-1 target gene VEGF-A in AC 
prevented injury-induced BBB disruption and improved 
outcome in the same study [25] and an in  vitro model 
of Alzheimer disease [34]. As we noted increased VEGF 
mRNA levels during hypoxic exposure despite HIF-1 
blockade, similar to others [35], the data clearly suggests 
a HIF-1 independent pathway contributes to AC VEGF 
levels. How the specificity arises that VEGF secreted by 
AC does not induce angiogenesis is unclear, but different 
(See figure on next page.)
Fig. 6 Protection of barrier functionality by AC‑CM is independent of HIF‑1. a Immunostaining of confluent RBE4 labeled for ZO‑1 (green) and cell 
nuclei (DAPI, blue). Cells were cultured in RBE4 or AC conditioned media under normoxia or hypoxia for 24 h. Hypoxia‑induced disruption of ZO‑1 
(arrows) and inter‑endothelial gap formation (asterisks) is seen at cell–cell borders. Scale bar = 50 μm. b Phalloidin (white) and DAPI stain (blue) of 
confluent RBE4 monolayers after 24 h normoxic or hypoxic exposure with AC‑CM or RBE4 media. Arrows indicate hypoxic stress fiber formation, 
asterisks highlight inter‑endothelial gap formation. Enhanced images, scale bar = 25 μm. c Permeability assays were performed on confluent RBE4 
on Transwell inserts. Cells were treated with RBE4 media or AC‑CM for 24 h. Results are compared to normoxic baseline (dotted line). 2way ANOVA, 
mean ± SD, n = 3–4, *p < 0.05, **p < 0.01 compared to RBE4 media




Page 12 of 14Baumann et al. Fluids Barriers CNS           (2021) 18:13 
isoforms of VEGF and its receptors clearly exist. In fact, 
virtually all cells are known to express a VEGF splice vari-
ant called  VEGF165b that exhibits anti-angiogenic prop-
erties abrogating normal manifestation of the standard 
isoform [36]. Whether AC VEGF includes this splice var-
iant and/or an intricate and complex cell-specific distri-
bution exists is yet to be studied. The question then arises 
why produce angiogenic molecules if not to modulate the 
brain endothelium? Data clearly shows that VEGF is not 
only a vasoactive factor but also, similar to HIF-1, cyto-
protective and neuroprotective [37]. Indeed endogenous 
VEGF secretion during injury increased astrocyte sur-
vival and proliferation per se [35, 38]. Similarly, protec-
tion of the endothelium rather than activation is likely. It 
is also feasible that multiple astrocyte-derived factors are 
directed primarily towards neurons and not the endothe-
lium. In line with this notion primary rat AC were shown 
to polarize VEGF secretion to the extracellular matrix 
and thus spatially restrict its concentrations [39]. Further 
research on cell-specific isoforms, direction of secretion 
and targets of AC paracrine signaling would provide con-
siderable insight.
A critical balancing act of EC quiescence and/or acti-
vation is required in all vascular structures. In non-brain 
vasculature, hypoxic activation of the endothelium can 
result in the formation of life-saving collateral vessels but 
also contribute to numerous pathologies [40]. In contrast, 
in the healthy adult CNS retaining a viable yet angiostatic 
quiescent EC status ensures an impermeable and stable 
BBB [41, 42]. Despite using a cell line that is very hypoxia 
responsive, i.e. as opposed to primary ECs that are much 
more quiescent, our data underlines the fact that AC con-
ditioned media constantly preserves the barrier function-
ality. AC are perfect partners being highly adaptable to 
stress stimuli and able to fulfill protective roles even dur-
ing severe conditions [4, 43]. Paracrine signaling clearly 
plays a key role in maintaining this vascular equilibrium 
as AC-CM consistently prevented hypoxia-induced EC 
activation by arresting the cells in the G0 cell cycle stage 
and suppressing injury-mediated BBB permeability. Sev-
eral other in  vitro studies also showed AC co-culture 
[44–46] or AC-CM [47] improves EC barrier integrity 
and suppresses proliferation [31]. Anti-migratory effects 
of AC paracrine signaling on the mouse retinal endothe-
lium [48] and intriguingly on neighbouring Schwann cells 
[49] have also been reported. It seems likely that many 
AC-derived factors can protect the barrier endothelium. 
In in vitro model of CNS inflammation AC secretion of 
retinoic acid prevented EC oxidative stress and improved 
BBB despite the inflammatory environment [50]. Secre-
tion of apolipoprotein E [51] and inflammation-associ-
ated pentraxin 3 [52] protected the BBB during ischemic 
injury. A diverse array of metabolites are also increased 
by AC during injury conditions that can potentially aid 
EC function [4]. A good example is glutathione, an anti-
oxidant directly shuttled from AC to EC [53] that pre-
vents barrier disturbance during hypoxia and ischemia 
[53, 54]. Overall however, blocking HIF-1 mediated sign-
aling did not detectably alter AC positive effects.
Some limitations of this study should be acknowledged. 
The work was conducted with an in  vitro model of the 
BBB and such models are known to harbour some limita-
tions in relation to the in  vivo situation. As our experi-
mental design utilized transfer of conditioned AC media 
to EC, any additional influence of endothelial-derived 
stress signals and/or crosstalk between the cells on the 
AC secretory response is not elucidated herein. We also 
cannot exclude that exposing the cells to a more signifi-
cant insult such as oxygen glucose deprivation (ischemia) 
might result in a different outcome. Future co-culture 
experiments will provide more insight.
Conclusions
In conclusion, this study demonstrates that AC HIF-1 
dependent paracrine signaling does not disrupt the 
endothelial barrier during hypoxia. It does however high-
light the incessant protective effect of AC on the barrier 
endothelium. Exploring mechanisms of AC protection 
and especially the factors they secrete in more detail will 
provide essential insight on ways to support the BBB dur-
ing injury and neurological disease.
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